According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
Separately, Jefferies Group restated a hold rating on shares of VCA in a research note on Friday, August 5th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. VCA has a consensus rating of Buy and a consensus target price of $71.00.
VCA (NASDAQ:WOOF) opened at 69.82 on Wednesday. The stock has a 50 day moving average price of $70.32 and a 200 day moving average price of $66.04. The company has a market capitalization of $5.65 billion, a price-to-earnings ratio of 24.91 and a beta of 1.23. VCA has a 12-month low of $44.00 and a 12-month high of $73.69.
VCA (NASDAQ:WOOF) last issued its earnings results on Wednesday, July 27th. The company reported $0.87 EPS for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.05. The business had revenue of $653.50 million for the quarter, compared to the consensus estimate of $637.18 million. VCA had a net margin of 9.93% and a return on equity of 16.86%. The company’s revenue for the quarter was up 19.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.70 EPS. On average, analysts expect that VCA will post $2.93 EPS for the current year.
In other news, Director John B. Chickering, Jr. sold 2,302 shares of the stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $70.85, for a total transaction of $163,096.70. Following the transaction, the director now directly owns 10,992 shares in the company, valued at $778,783.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Arthur J. Antin sold 34,000 shares of the stock in a transaction that occurred on Friday, September 16th. The shares were sold at an average price of $69.03, for a total transaction of $2,347,020.00. Following the transaction, the chief operating officer now owns 89,691 shares in the company, valued at $6,191,369.73. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in WOOF. Norges Bank acquired a new position in VCA during the fourth quarter worth about $44,158,000. Aperio Group LLC increased its position in VCA by 35.0% in the first quarter. Aperio Group LLC now owns 14,274 shares of the company’s stock worth $823,000 after buying an additional 3,697 shares in the last quarter. Virginia Retirement System acquired a new position in VCA during the first quarter worth about $1,788,000. Ramsey Quantitative Systems acquired a new position in VCA during the first quarter worth about $554,000. Finally, Pacad Investment Ltd. acquired a new position in VCA during the first quarter worth about $270,000. Hedge funds and other institutional investors own 91.17% of the company’s stock.
VCA Inc is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.